Skip to main content
Erschienen in: Breast Cancer Research and Treatment 2/2013

01.07.2013 | Epidemiology

The Athena Breast Health Network: developing a rapid learning system in breast cancer prevention, screening, treatment, and care

verfasst von: Sarah L. Elson, Robert A. Hiatt, Hoda Anton-Culver, Lydia P. Howell, Arash Naeim, Barbara A. Parker, Laura J. van’t Veer, Michael Hogarth, John P. Pierce, Robert J. DuWors, Kathy Hajopoulos, Laura J. Esserman, The Athena Breast Health Network

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

The term breast cancer covers many different conditions, whose clinical course ranges from indolent to aggressive. However, current practice in breast cancer prevention and care, and in breast cancer epidemiology, does not take into account the heterogeneity of the disease. A comprehensive understanding of the etiology and progression of different breast cancer subtypes would enable a more patient-centered approach to breast health care: assessing an individual’s risk of getting specific subtypes of the disease, providing risk-based screening and prevention recommendations, and, for those diagnosed with the disease, tailored treatment options based on risk and timing of progression and mortality. The Athena Breast Health Network is an initiative of the five University of California medical and cancer centers to prototype this approach and to enable the development of a rapid learning system—connecting risk and outcome information from a heterogeneous patient population in real time and using new knowledge from research to continuously improve the quality of care. The Network is based on integrating clinical and research processes to create a comprehensive approach to accelerating patient-centered breast health care. Since its inception in 2009, the Network has developed a multi-site, transdisciplinary collaboration that enables the learning system. The five-campus collaboration has implemented a shared informatics platform, standardized electronic patient intake questionnaires, and common biospecimen protocols, as well as new clinical programs and multi-center research projects. The Athena Breast Health Network can serve as a model of a rapid learning system that integrates epidemiologic, behavioral, and clinical research with clinical care improvements.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Ellsworth RE, Decewicz DJ, Shriver CD, Ellsworth DL (2010) Breast cancer in the personal genomics era. Curr Genomics 11(3):146–161PubMedCrossRef Ellsworth RE, Decewicz DJ, Shriver CD, Ellsworth DL (2010) Breast cancer in the personal genomics era. Curr Genomics 11(3):146–161PubMedCrossRef
2.
Zurück zum Zitat Esserman LJ, Moore DH, Tsing PJ, Chu PW, Yau C, Ozanne E, Chung RE, Tandon VJ, Park JW, Baehner FL, Kreps S, Tutt AN, Gillett CE, Benz CC (2011) Biologic markers determine both the risk and the timing of recurrence in breast cancer. Breast Cancer Res Treat 129(2):607–616PubMedCrossRef Esserman LJ, Moore DH, Tsing PJ, Chu PW, Yau C, Ozanne E, Chung RE, Tandon VJ, Park JW, Baehner FL, Kreps S, Tutt AN, Gillett CE, Benz CC (2011) Biologic markers determine both the risk and the timing of recurrence in breast cancer. Breast Cancer Res Treat 129(2):607–616PubMedCrossRef
3.
Zurück zum Zitat National Research Council (US) Committee on A Framework for Developing a New Taxonomy of Disease (2011) Toward precision medicine building a knowledge network for biomedical research and a new taxonomy of disease. The National Academies Press, Washington, DC National Research Council (US) Committee on A Framework for Developing a New Taxonomy of Disease (2011) Toward precision medicine building a knowledge network for biomedical research and a new taxonomy of disease. The National Academies Press, Washington, DC
4.
Zurück zum Zitat Buyse M, Loi S, van’t Veer L, Viale G, Delorenzi M, Glas AM, d’Assignies MS, Bergh J, Lidereau R, Ellis P, Harris A, Bogaerts J, Therasse P, Floore A, Amakrane M, Piette F, Rutgers E, Sotiriou C, Cardoso F, Piccart MJ (2006) Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer. J Natl Cancer Inst 98(17):1183–1192PubMedCrossRef Buyse M, Loi S, van’t Veer L, Viale G, Delorenzi M, Glas AM, d’Assignies MS, Bergh J, Lidereau R, Ellis P, Harris A, Bogaerts J, Therasse P, Floore A, Amakrane M, Piette F, Rutgers E, Sotiriou C, Cardoso F, Piccart MJ (2006) Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer. J Natl Cancer Inst 98(17):1183–1192PubMedCrossRef
5.
Zurück zum Zitat Paik S, Tang G, Shak S, Kim C, Baker J, Kim W, Cronin M, Baehner FL, Watson D, Bryant J, Costantino JP, Geyer CE Jr, Wickerham DL, Wolmark N (2006) Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol 24(23):3726–3734PubMedCrossRef Paik S, Tang G, Shak S, Kim C, Baker J, Kim W, Cronin M, Baehner FL, Watson D, Bryant J, Costantino JP, Geyer CE Jr, Wickerham DL, Wolmark N (2006) Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol 24(23):3726–3734PubMedCrossRef
6.
Zurück zum Zitat Abernethy AP, Etheredge LM, Ganz PA, Wallace P, German RR, Neti C, Bach PB, Murphy SB (2010) Rapid-learning system for cancer care. J Clin Oncol 28(27):4268–4274PubMedCrossRef Abernethy AP, Etheredge LM, Ganz PA, Wallace P, German RR, Neti C, Bach PB, Murphy SB (2010) Rapid-learning system for cancer care. J Clin Oncol 28(27):4268–4274PubMedCrossRef
7.
Zurück zum Zitat Institute of Medicine (US) and National Academy of Engineering (US) Roundtable on Value & Science-Driven Health Care (2011) Engineering a learning healthcare system: A look at the future: workshop summary. The National Academies Press, Washington DC Institute of Medicine (US) and National Academy of Engineering (US) Roundtable on Value & Science-Driven Health Care (2011) Engineering a learning healthcare system: A look at the future: workshop summary. The National Academies Press, Washington DC
8.
Zurück zum Zitat Luce BR, Kramer JM, Goodman SN, Connor JT, Tunis S, Whicher D, Schwartz JS (2009) Rethinking randomized clinical trials for comparative effectiveness research: the need for transformational change. Ann Intern Med 151(3):206–209PubMedCrossRef Luce BR, Kramer JM, Goodman SN, Connor JT, Tunis S, Whicher D, Schwartz JS (2009) Rethinking randomized clinical trials for comparative effectiveness research: the need for transformational change. Ann Intern Med 151(3):206–209PubMedCrossRef
9.
Zurück zum Zitat Bast RC Jr, Lilja H, Urban N, Rimm DL, Fritsche H, Gray J, Veltri R, Klee G, Allen A, Kim N, Gutman S, Rubin MA, Hruszkewycz A (2005) Translational crossroads for biomarkers. Clin Cancer Res 11(17):6103–6108PubMedCrossRef Bast RC Jr, Lilja H, Urban N, Rimm DL, Fritsche H, Gray J, Veltri R, Klee G, Allen A, Kim N, Gutman S, Rubin MA, Hruszkewycz A (2005) Translational crossroads for biomarkers. Clin Cancer Res 11(17):6103–6108PubMedCrossRef
10.
Zurück zum Zitat Hood L, Friend SH (2011) Predictive, personalized, preventive, participatory (P4) cancer medicine. Nat Rev Clin Oncol 8(3):184–187PubMedCrossRef Hood L, Friend SH (2011) Predictive, personalized, preventive, participatory (P4) cancer medicine. Nat Rev Clin Oncol 8(3):184–187PubMedCrossRef
11.
Zurück zum Zitat Sung NS, Crowley WF Jr, Genel M, Salber P, Sandy L, Sherwood LM, Johnson SB, Catanese V, Tilson H, Getz K, Larson EL, Scheinberg D, Reece EA, Slavkin H, Dobs A, Grebb J, Martinez RA, Korn A, Rimoin D (2003) Central challenges facing the national clinical research enterprise. JAMA 289(10):1278–1287PubMedCrossRef Sung NS, Crowley WF Jr, Genel M, Salber P, Sandy L, Sherwood LM, Johnson SB, Catanese V, Tilson H, Getz K, Larson EL, Scheinberg D, Reece EA, Slavkin H, Dobs A, Grebb J, Martinez RA, Korn A, Rimoin D (2003) Central challenges facing the national clinical research enterprise. JAMA 289(10):1278–1287PubMedCrossRef
12.
Zurück zum Zitat Disis ML, Slattery JT (2010) The road we must take: multidisciplinary team science. Sci Transl Med 2(22):22–29CrossRef Disis ML, Slattery JT (2010) The road we must take: multidisciplinary team science. Sci Transl Med 2(22):22–29CrossRef
13.
Zurück zum Zitat Hiatt RA, Breen N (2008) The social determinants of cancer: a challenge for transdisciplinary science. Am J Prev Med 35(2 Suppl):S141–S150PubMedCrossRef Hiatt RA, Breen N (2008) The social determinants of cancer: a challenge for transdisciplinary science. Am J Prev Med 35(2 Suppl):S141–S150PubMedCrossRef
14.
Zurück zum Zitat Evans DG, Howell A (2007) Breast cancer risk-assessment models. Breast cancer research 9(5):213PubMedCrossRef Evans DG, Howell A (2007) Breast cancer risk-assessment models. Breast cancer research 9(5):213PubMedCrossRef
15.
Zurück zum Zitat Ozanne EM, Annis C, Adduci K, Showstack J, Esserman L (2007) Pilot trial of a computerized decision aid for breast cancer prevention. Breast J 13(2):147–154PubMedCrossRef Ozanne EM, Annis C, Adduci K, Showstack J, Esserman L (2007) Pilot trial of a computerized decision aid for breast cancer prevention. Breast J 13(2):147–154PubMedCrossRef
16.
Zurück zum Zitat Nelson HD, Zakher B, Cantor A, Fu R, Griffin J, O’Meara ES, Buist DS, Kerlikowske K, van Ravesteyn NT, Trentham-Dietz A, Mandelblatt JS, Miglioretti DL (2012) Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med 156(9):635–648PubMedCrossRef Nelson HD, Zakher B, Cantor A, Fu R, Griffin J, O’Meara ES, Buist DS, Kerlikowske K, van Ravesteyn NT, Trentham-Dietz A, Mandelblatt JS, Miglioretti DL (2012) Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med 156(9):635–648PubMedCrossRef
17.
Zurück zum Zitat Walter LC, Lewis CL, Barton MB (2005) Screening for colorectal, breast, and cervical cancer in the elderly: a review of the evidence. Am J Med 118(10):1078–1086PubMedCrossRef Walter LC, Lewis CL, Barton MB (2005) Screening for colorectal, breast, and cervical cancer in the elderly: a review of the evidence. Am J Med 118(10):1078–1086PubMedCrossRef
18.
Zurück zum Zitat Cummings SR, Tice JA, Bauer S, Browner WS, Cuzick J, Ziv E, Vogel V, Shepherd J, Vachon C, Smith-Bindman R, Kerlikowske K (2009) Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk. J Natl Cancer Inst 101(6):384–398PubMedCrossRef Cummings SR, Tice JA, Bauer S, Browner WS, Cuzick J, Ziv E, Vogel V, Shepherd J, Vachon C, Smith-Bindman R, Kerlikowske K (2009) Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk. J Natl Cancer Inst 101(6):384–398PubMedCrossRef
19.
Zurück zum Zitat Patterson RE, Cadmus LA, Emond JA, Pierce JP (2010) Physical activity, diet, adiposity and female breast cancer prognosis: a review of the epidemiologic literature. Maturitas 66(1):5–15PubMedCrossRef Patterson RE, Cadmus LA, Emond JA, Pierce JP (2010) Physical activity, diet, adiposity and female breast cancer prognosis: a review of the epidemiologic literature. Maturitas 66(1):5–15PubMedCrossRef
20.
Zurück zum Zitat Elmore JG, Jackson SL, Abraham L, Miglioretti DL, Carney PA, Geller BM, Yankaskas BC, Kerlikowske K, Onega T, Rosenberg RD, Sickles EA, Buist DS (2009) Variability in interpretive performance at screening mammography and radiologists’ characteristics associated with accuracy. Radiology 253(3):641–651PubMedCrossRef Elmore JG, Jackson SL, Abraham L, Miglioretti DL, Carney PA, Geller BM, Yankaskas BC, Kerlikowske K, Onega T, Rosenberg RD, Sickles EA, Buist DS (2009) Variability in interpretive performance at screening mammography and radiologists’ characteristics associated with accuracy. Radiology 253(3):641–651PubMedCrossRef
21.
Zurück zum Zitat Bueno-de-Mesquita JM, Nuyten DS, Wesseling J, van Tinteren H, Linn SC, van de Vijver MJ (2010) The impact of inter-observer variation in pathological assessment of node-negative breast cancer on clinical risk assessment and patient selection for adjuvant systemic treatment. Ann Oncol 21(1):40–47PubMedCrossRef Bueno-de-Mesquita JM, Nuyten DS, Wesseling J, van Tinteren H, Linn SC, van de Vijver MJ (2010) The impact of inter-observer variation in pathological assessment of node-negative breast cancer on clinical risk assessment and patient selection for adjuvant systemic treatment. Ann Oncol 21(1):40–47PubMedCrossRef
22.
Zurück zum Zitat Dowsett M, Nielsen TO, A’Hern R, Bartlett J, Coombes RC, Cuzick J, Ellis M, Henry NL, Hugh JC, Lively T, McShane L, Paik S, Penault-Llorca F, Prudkin L, Regan M, Salter J, Sotiriou C, Smith IE, Viale G, Zujewski JA, Hayes DF (2011) Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group. J Natl Cancer Inst 103(22):1656–1664PubMedCrossRef Dowsett M, Nielsen TO, A’Hern R, Bartlett J, Coombes RC, Cuzick J, Ellis M, Henry NL, Hugh JC, Lively T, McShane L, Paik S, Penault-Llorca F, Prudkin L, Regan M, Salter J, Sotiriou C, Smith IE, Viale G, Zujewski JA, Hayes DF (2011) Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group. J Natl Cancer Inst 103(22):1656–1664PubMedCrossRef
23.
Zurück zum Zitat Cuzick J, Dowsett M, Pineda S, Wale C, Salter J, Quinn E, Zabaglo L, Mallon E, Green AR, Ellis IO, Howell A, Buzdar AU, Forbes JF (2011) Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer. J Clin Oncol 29(32):4273–4278PubMedCrossRef Cuzick J, Dowsett M, Pineda S, Wale C, Salter J, Quinn E, Zabaglo L, Mallon E, Green AR, Ellis IO, Howell A, Buzdar AU, Forbes JF (2011) Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer. J Clin Oncol 29(32):4273–4278PubMedCrossRef
25.
Zurück zum Zitat Hahn EE, Ganz PA, Melisko ME, Pierce JP, von Friederichs-Fitzwater M, Lane KT, Hiatt RA (2013) Provider perceptions and expectations of breast cancer posttreatment care: a University of California Athena Breast Health Network project. J Cancer Surviv. doi:10.1007/s11764-013-0269-7 Hahn EE, Ganz PA, Melisko ME, Pierce JP, von Friederichs-Fitzwater M, Lane KT, Hiatt RA (2013) Provider perceptions and expectations of breast cancer posttreatment care: a University of California Athena Breast Health Network project. J Cancer Surviv. doi:10.​1007/​s11764-013-0269-7
26.
Zurück zum Zitat Natarajan L, Pu M, Parker BA, Thomson CA, Caan BJ, Flatt SW, Madlensky L, Hajek RA, Al-Delaimy WK, Saquib N, Gold EB, Pierce JP (2009) Time-varying effects of prognostic factors associated with disease-free survival in breast cancer. Am J Epidemiol 169(12):1463–1470PubMedCrossRef Natarajan L, Pu M, Parker BA, Thomson CA, Caan BJ, Flatt SW, Madlensky L, Hajek RA, Al-Delaimy WK, Saquib N, Gold EB, Pierce JP (2009) Time-varying effects of prognostic factors associated with disease-free survival in breast cancer. Am J Epidemiol 169(12):1463–1470PubMedCrossRef
Metadaten
Titel
The Athena Breast Health Network: developing a rapid learning system in breast cancer prevention, screening, treatment, and care
verfasst von
Sarah L. Elson
Robert A. Hiatt
Hoda Anton-Culver
Lydia P. Howell
Arash Naeim
Barbara A. Parker
Laura J. van’t Veer
Michael Hogarth
John P. Pierce
Robert J. DuWors
Kathy Hajopoulos
Laura J. Esserman
The Athena Breast Health Network
Publikationsdatum
01.07.2013
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 2/2013
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-013-2612-0

Weitere Artikel der Ausgabe 2/2013

Breast Cancer Research and Treatment 2/2013 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.